Senate
File
2222
-
Introduced
SENATE
FILE
2222
BY
COMMITTEE
ON
COMMERCE
(SUCCESSOR
TO
SSB
3082)
A
BILL
FOR
An
Act
relating
to
the
prescribing
and
dispensing
of
1
self-administered
oral
hormonal
contraceptives
including
2
by
pharmacists
and
providing
insurance
coverage
for
such
3
contraceptives
prescribed
and
dispensed.
4
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
5
TLSB
5041SV
(2)
86
pf/nh
S.F.
2222
Section
1.
Section
155A.3,
Code
2016,
is
amended
by
adding
1
the
following
new
subsection:
2
NEW
SUBSECTION
.
39A.
“Self-administered
oral
hormonal
3
contraceptive”
means
a
drug
composed
of
a
combination
of
4
hormones
that
is
approved
by
the
United
States
food
and
drug
5
administration
to
prevent
pregnancy
and
that
the
patient
to
6
whom
the
drug
is
prescribed
may
take
orally.
7
Sec.
2.
NEW
SECTION
.
155A.45
Prescribing
and
dispensing
of
8
self-administered
oral
hormonal
contraceptives.
9
1.
Notwithstanding
any
provision
of
law
to
the
contrary,
10
a
pharmacist
may
prescribe
and
dispense
self-administered
11
oral
hormonal
contraceptives
to
a
person
regardless
of
12
whether
the
person
has
evidence
of
a
previous
prescription
13
from
a
practitioner
for
a
self-administered
oral
hormonal
14
contraceptive.
15
2.
a.
The
department
of
public
health
in
consultation
with
16
the
Iowa
pharmacy
association
and
the
Iowa
medical
society,
and
17
in
consideration
of
the
guidelines
established
by
the
American
18
congress
of
obstetricians
and
gynecologists,
shall
adopt
by
19
rule
a
statewide
protocol
for
the
prescribing
and
dispensing
of
20
self-administered
oral
hormonal
contraceptives
by
pharmacists.
21
b.
The
rules
adopted
under
this
subsection
shall
require
a
22
pharmacist
to
do
all
of
the
following:
23
(1)
Complete
a
standardized
training
program
approved
by
24
the
department
of
public
health
that
is
related
to
prescribing
25
self-administered
oral
hormonal
contraceptives
and
includes
26
education
regarding
all
contraceptive
methods
approved
by
the
27
federal
food
and
drug
administration.
28
(2)
Provide
a
standardized
self-screening
risk
assessment
29
tool
to
the
patient
for
completion
prior
to
the
pharmacist’s
30
prescribing
of
the
self-administered
oral
hormonal
31
contraceptive.
32
(3)
Prior
to
prescribing
and
dispensing
the
33
self-administered
oral
hormone
contraceptive,
provide
34
the
patient
with
education
regarding
all
contraceptive
methods
35
-1-
LSB
5041SV
(2)
86
pf/nh
1/
4
S.F.
2222
approved
by
the
federal
food
and
drug
administration.
1
(4)
Upon
prescribing
and
dispensing
the
self-administered
2
oral
hormonal
contraceptive,
provide
the
patient
with
a
written
3
record
of
the
prescribed
and
dispensed
self-administered
oral
4
hormonal
contraceptive,
and
refer
the
patient
to
the
patient’s
5
primary
practitioner
or
women’s
health
care
practitioner
for
6
preventive
visits.
7
(5)
Dispense
the
self-administered
oral
hormonal
8
contraceptive
to
the
patient
as
soon
as
practicable
after
the
9
pharmacist
issues
the
prescription.
10
c.
The
rules
adopted
under
this
subsection
shall
require
11
a
pharmacist
to
prescribe
and
dispense
an
initial
three-month
12
supply
of
the
self-administered
oral
hormonal
contraceptive,
13
and
shall
authorize
a
pharmacist,
upon
verification
of
no
14
adverse
effects,
to
issue
a
prescription
for
and
dispense
15
up
to
a
one-year
supply
of
self-administered
oral
hormonal
16
contraceptives
to
the
patient
at
one
time.
17
d.
The
rules
adopted
under
this
subsection
shall
prohibit
a
18
pharmacist
from
requiring
a
patient
to
schedule
an
appointment
19
with
the
pharmacist
for
the
prescribing
of
a
self-administered
20
oral
hormonal
contraceptive.
21
3.
All
state
and
federal
laws
governing
insurance
coverage
22
of
contraceptive
drugs,
devices,
products,
and
services
shall
23
apply
to
a
self-administered
oral
hormonal
contraceptive
24
prescribed
by
a
pharmacist
under
this
section.
25
Sec.
3.
Section
514C.19,
subsection
1,
paragraph
a,
Code
26
2016,
is
amended
to
read
as
follows:
27
a.
Exclude
or
restrict
benefits
for
prescription
28
contraceptive
drugs
or
prescription
contraceptive
devices
29
which
prevent
conception
and
which
are
approved
by
the
United
30
States
food
and
drug
administration,
or
generic
equivalents
31
approved
as
substitutable
by
the
United
States
food
and
drug
32
administration,
if
such
policy
or
contract
provides
benefits
33
for
other
outpatient
prescription
drugs
or
devices.
Such
34
policy
or
contract
shall
specifically
provide
for
payment
35
-2-
LSB
5041SV
(2)
86
pf/nh
2/
4
S.F.
2222
of
up
to
a
one-year
supply,
dispensed
at
one
time,
of
1
self-administered
oral
hormonal
contraceptives
as
defined
2
in
section
155A.3,
which
are
prescribed
by
a
practitioner
3
authorized
to
prescribe
drugs
in
this
state,
including
a
4
pharmacist
pursuant
to
section
155A.45.
5
EXPLANATION
6
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
7
the
explanation’s
substance
by
the
members
of
the
general
assembly.
8
This
bill
authorizes
a
pharmacist
to
prescribe
and
dispense
9
self-administered
oral
hormonal
contraceptives.
Under
the
10
bill,
a
pharmacist
may
prescribe
and
dispense
these
items
to
11
a
person
whether
or
not
the
person
has
evidence
of
a
previous
12
prescription
from
a
practitioner
for
self-administered
oral
13
hormonal
contraceptives.
14
The
department
of
public
health
in
consultation
with
15
the
Iowa
pharmacy
association
and
the
Iowa
medical
society,
16
and
in
consideration
of
the
guidelines
established
by
the
17
American
congress
of
obstetricians
and
gynecologists,
is
18
directed
to
adopt
a
statewide
protocol
for
the
prescribing
and
19
dispensing
of
self-administered
oral
hormonal
contraceptives
20
by
pharmacists.
21
The
bill
prescribes
what
the
rules
are
to
require
a
22
pharmacist
to
do
and
what
a
pharmacist
is
prohibited
from
23
doing.
The
rules
shall
require
a
pharmacist
to
complete
a
24
standardized
training
program
approved
by
the
department
of
25
public
health
that
is
related
to
prescribing
self-administered
26
oral
hormonal
contraceptives
and
includes
education
regarding
27
all
contraceptive
methods
approved
by
the
federal
food
and
drug
28
administration
(FDA);
to
provide
a
standardized
self-screening
29
risk
assessment
tool
to
the
patient
for
completion
prior
to
30
the
pharmacist’s
prescribing
of
the
self-administered
oral
31
hormonal
contraceptive;
prior
to
prescribing
and
dispensing
32
the
self-administered
oral
hormonal
contraceptive,
to
provide
33
the
patient
with
education
regarding
all
contraceptive
methods
34
approved
by
the
FDA;
upon
prescribing
and
dispensing
the
35
-3-
LSB
5041SV
(2)
86
pf/nh
3/
4
S.F.
2222
self-administered
oral
hormonal
contraceptive,
to
provide
1
the
patient
with
a
written
record
of
the
prescribed
and
2
dispensed
self-administered
oral
hormonal
contraceptive,
and
3
refer
the
patient
to
the
patient’s
primary
practitioner
or
4
women’s
health
care
practitioner
for
preventive
visits;
and
5
to
dispense
the
self-administered
oral
hormonal
contraceptive
6
to
the
patient
as
soon
as
practicable
after
the
pharmacist
7
issues
the
prescription.
The
bill
provides
that
the
rules
8
adopted
are
to
require
a
pharmacist
to
prescribe
and
dispense
9
an
initial
three-month
supply
of
the
self-administered
oral
10
hormonal
contraceptive
and
authorize
a
pharmacist,
upon
11
verification
of
no
adverse
effects,
to
issue
a
prescription
12
for
and
dispense
up
to
a
one-year
supply
of
self-administered
13
oral
hormonal
contraceptives
to
the
patient
at
one
time.
The
14
rules
shall
prohibit
a
pharmacist
from
requiring
a
patient
to
15
schedule
an
appointment
with
the
pharmacist
for
prescribing
the
16
self-administered
oral
hormonal
contraceptive.
17
All
state
and
federal
laws
governing
insurance
coverage
of
18
contraceptive
drugs,
devices,
products,
and
services
apply
to
a
19
self-administered
oral
hormonal
contraceptive
prescribed
by
a
20
pharmacist
under
the
bill.
21
The
bill
amends
prescription
contraceptive
coverage
22
provisions
to
require
that
a
group
policy
or
contract
providing
23
for
third-party
payment
or
prepayment
of
health
or
medical
24
expenses,
and
by
reference
individual
policies
as
well,
25
shall
specifically
provide
for
payment
of
up
to
a
one-year
26
supply,
dispensed
at
one
time,
of
self-administered
oral
27
hormonal
contraceptives
which
are
prescribed
by
a
practitioner
28
authorized
to
prescribe
drugs
in
this
state,
including
a
29
pharmacist
pursuant
to
Code
section
155A.45.
30
-4-
LSB
5041SV
(2)
86
pf/nh
4/
4